Alliancebernstein L.P. Zentalis Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$280 Billion
Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 109,538 shares of ZNTL stock, worth $266,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,538

Previous 109,538 -0.0%

Holding current value

$266,177

Previous $402,000 17.66%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.9 - $4.57 $3,480 - $5,484	-1,200 Reduced 1.08%	109,538 $402,000
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $216,851 - $855,212	53,020 Added 91.86%	110,738 $452,000
Q3 2023 Nov 14, 2023	SELL	$19.63 - $28.29 $24.8 Million - $35.8 Million	-1,263,717 Reduced 95.63%	57,718 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$17.41 - $30.05 $542,129 - $935,726	31,139 Added 2.41%	1,321,435 $37.3 Million
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $1.21 Million - $1.88 Million	-75,202 Reduced 5.51%	1,290,296 $22.2 Million
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $607,404 - $860,518	33,614 Added 2.52%	1,365,498 $27.5 Million
Q3 2022 Nov 15, 2022	SELL	$20.23 - $31.73 $456,773 - $716,431	-22,579 Reduced 1.67%	1,331,884 $28.8 Million
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $6.41 Million - $18.7 Million	357,704 Added 35.89%	1,354,463 $38.1 Million
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $2.9 Million - $5.65 Million	69,822 Added 7.53%	996,759 $46 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $3.95 Million - $5 Million	-59,016 Reduced 5.99%	926,937 $77.9 Million
Q3 2021 Nov 10, 2021	BUY	$46.83 - $73.5 $2.11 Million - $3.32 Million	45,125 Added 4.8%	985,953 $65.7 Million
Q2 2021 Jul 30, 2021	SELL	$37.41 - $62.25 $6.15 Million - $10.2 Million	-164,454 Reduced 14.88%	940,828 $50.1 Million
Q1 2021 May 06, 2021	BUY	$35.69 - $52.72 $9.67 Million - $14.3 Million	270,834 Added 32.46%	1,105,282 $48 Million
Q4 2020 Feb 08, 2021	BUY	$31.71 - $57.97 $2.02 Million - $3.69 Million	63,678 Added 8.26%	834,448 $43.3 Million
Q3 2020 Nov 12, 2020	BUY	$27.03 - $47.97 $7.37 Million - $13.1 Million	272,498 Added 54.69%	770,770 $25.2 Million
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $11.6 Million - $27.3 Million	498,272 New	498,272 $23.9 Million

Others Institutions Holding ZNTL

# of Institutions

148

Shares Held

64M

Call Options Held

55.5K

Put Options Held

71.4K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $138M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Zentalis Pharmaceuticals, Inc. Transaction History